Drug discovery
used to take
a decade. Now it's weeks.
SYNTH runs molecular dynamics simulations at scale, screening candidate compounds against target proteins before a single one touches a lab bench.
90% of drug candidates fail.
Most fail late — after years of lab work and hundreds of millions in spend. The bottleneck isn't chemistry, it's the sheer number of possible molecules nobody has time to test by hand.
Simulate first, synthesize second.
SYNTH's models predict how a candidate molecule will bind, fold, and behave — before it exists. What you're watching assemble is exactly that: a candidate structure forming atom by atom.
Wrong candidates, ruled out early.
Teams using SYNTH cut their pre-clinical screening timeline by removing dead ends before they cost anyone a lab budget or a year of work.
Fewer wrong turns.
Faster right ones.
"We stopped sending compounds to the lab that were never going to work. That alone bought us eight months."